The nitric oxide delivery systems by EKU Elektronik are used in ventilation of critically ill patients infected with COVID-19.
The NO-A is a therapy device for the application of nitric oxide (NO) therapy gas in the ventilation flow of an intensive care patient in connection with different ventilators.
The inhaled nitric oxide (iNO) therapy shall reduce the clinical necessity of a left-to-right shunt and contribute to cardiac relief. In order to improve the oxygenation of ventilated patients nitric oxide (NO) is added to the respiratory gas.
It is applied for the treatment of newborns, children and adults with pulmonary hypertension, oxygen deficiency, neonatal pulmonary failure, persistent pulmonary hypertension of neonates, pulmonary fibrosis, chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS). Furthermore the device is used in cardiac surgery (cardiac valve diseases and cardiac transplantation) to treat an increased pulmonary pressure, as inhaled NO has a dilating effect on the blood vessels in the lung and therefore significantly improves the haemodynamics of the patient. Please refer to the relevant details listed in the information accompanying the finished medicinal product.
EKU Elektronik is the only manufacturer of nitric oxide delivery systems with electronic connection (interface) to different ventilators of well-known manufacturers. By the connection to the ventilator the required volume is automatically dosed close to the patient corresponding to the adjusted target concentration. Furthermore the NO-A offers optional compatibility to almost any ventilator by using the external flow sensor. The NO-A flow sensor is installed in the ventilation circuit, measures the real flow in the inspiratory way and enables automatic dosing of the required volume.